Ascentage Pharma Group International is a biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies for cancer, hepatitis, and age-related dise... Ascentage Pharma Group International is a biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies for cancer, hepatitis, and age-related diseases. Known for its expertise in apoptosis-targeted drug discovery, Ascentage Pharma focuses on developing first-in-class or best-in-class therapies that address unmet medical needs. The company is deeply involved in advancing oncology therapeutics, with a robust portfolio of small-molecule drugs designed to inhibit or promote apoptosis in diseased cells. Its strategic operations span pre-clinical and clinical trials, aiming to bring novel treatments to market that significantly impact the oncology and age-related disease sectors. Ascentage Pharma plays a critical role in the pharmaceutical industry by pushing the boundaries of traditional therapeutic methods and contributing to the overall progress in life sciences and biotechnology. Listed in Hong Kong, the company has garnered attention for its collaborations and partnerships with researchers and academic institutions worldwide, emphasizing its commitment to global health improvements.Show lessShow more

Disclosures ESG Data Financial Data

Income Statement Balance Sheet Group Entities

Data not available

Group Entities data not yet covered for Ascentage Pharma

We have not yet reviewed Ascentage Pharma's disclosures for Group Entities data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review Ascentage Pharma's data?

Start your 30-day free trial to request a data review for Ascentage Pharma.

Start Free Trial

Legal Center Contact Us